Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
---|---|---|---|---|---|---|---|---|---|
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 1,250p | ― | 0.80% | Assigned | ||||
AstraZeneca | BUY 14,000p | ― | -1.10% | Reiterated | AstraZeneca (AZN) Receives a Buy from Barclays | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 170p | ― | 0.30% | Assigned | ||||
PageGroup | HOLD 455p→375p | ― | -13.30% | Reiterated | |||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 900p→1,000p | ― | 3.10% | Upgraded | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL 310p→330p | ― | 4.90% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 945p→1,000p | ― | 3.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD 415p→440p | ― | 3.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 280p | ― | 4.90% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 2,300p→2,200p | ― | 8.60% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 470p | ― | 6.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 2,180p | ― | 3.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD 165p→160p | ― | 10.60% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 350p→360p | ― | 15.50% | Reiterated | ||||
Bunzl plc | BUY 3,700p | ― | -1.70% | Upgraded | Bunzl plc (BNZL) was downgraded to a Buy Rating at Citi | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 1,140p | ― | 4.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 986p→1,353p | ― | 15.00% | Reiterated | ||||
B&M European Value Retail SA | HOLD 515p→350p | ― | 0.00% | Reiterated | Hold Rating Maintained for B&M European Value Retail SA Amid Sales Concerns | ||||
J Sainsbury plc | BUY 321p | ― | -3.30% | Reiterated | UBS Keeps Their Buy Rating on J Sainsbury plc (SBRY) | ||||
AstraZeneca | BUY 15,558p | ― | -3.40% | Reiterated | AstraZeneca (AZN) Receives a Buy from Goldman Sachs | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 1,137p | ― | 7.90% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 1,320p | ― | 7.40% | Reiterated | ||||
Hunting | BUY 450p | ― | -0.50% | Reiterated | Jefferies Keeps Their Buy Rating on Hunting (HTG) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 410p | ― | 4.00% | Reiterated | ||||
Schroders | HOLD 330p | ― | -8.60% | Reiterated | Jefferies Remains a Hold on Schroders (SDR) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 300p | ― | 3.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 280p | ― | 8.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 260p | ― | 8.10% | Reiterated | ||||
abrdn | HOLD 140p | ― | -3.70% | Reiterated | Jefferies Keeps Their Hold Rating on abrdn (ABDN) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 12,200p→13,150p | ― | 5.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 410p→400p | ― | 10.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 350p→360p | ― | 18.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL 349p→320p | ― | 10.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 310p→305p | ― | 10.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 1,250p→1,300p | ― | 7.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 2,720p→3,050p | ― | 0.50% | Upgraded | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 3,500p | ― | 2.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD | ― | 20.20% | Reiterated | ||||
Greencore | HOLD 165p→185p | ― | 0.00% | Reiterated | Cautious Optimism: Greencore's Financial Performance Spurs Hold Rating Amid Future Growth Uncertainties | ||||
Oxford Nanopore Technologies PLC | BUY 282p | ― | -12.70% | Reiterated | Berenberg Bank Sticks to Their Buy Rating for Oxford Nanopore Technologies PLC (ONT) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 1,400p→1,450p | ― | 8.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD 1,100p→1,250p | ― | 4.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD 180p | ― | 3.90% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 3,335p→2,585p | ― | 6.20% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 4,600p→5,500p | ― | 2.20% | Upgraded | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD 1,760p | ― | 6.20% | Upgraded | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD 410p | ― | 2.20% | Downgraded | ||||
Serco Group plc | HOLD 175p | ― | -1.70% | Downgraded | Serco Group plc Faces Earnings Headwinds and Contract Challenges Leading to Hold Rating | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY 415p | ― | 11.60% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD 3,670p→3,820p | ― | 4.80% | Reiterated |